Not independent
Tenure on this board
4.2 yrs
Meeting calendar
BHC · Annual meeting · Tuesday, May 19, 2026
Bausch Health Companies Inc
10 nominees · 3 ballot items.
Election of ten directors; advisory vote to approve executive compensation (say-on-pay); appointment of PricewaterhouseCoopers LLP as auditor and authorization for Board to set remuneration.
Market cap
$1.8B
1Y TSR
-26.3%
Board grade
C
Record date
Mar 20, 2026
Filing
DEF 14A
Meeting concluded · May 19, 2026
Follow how the vote landed and what changed on Bausch Health Companies Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
Proposals
On the ballot3
- 1
Election of Directors
ManagementBoard: FORElect ten directors to serve until the 2027 annual meeting.
- 2
Advisory Vote on Executive Compensation
ManagementBoard: FORNon-binding advisory vote to approve the compensation of named executive officers (say-on-pay).
More detail
The advisory proposal asks shareholders to approve, on a non-binding basis, the compensation of named executive officers as disclosed in the proxy materials, including the CD&A, tables and narrative. Management seeks shareholder approval to confirm its pay-for-performance approach linking incentive plans and long-term equity awards (PSUs tied to Adjusted Operating Cash Flow and rTSR) to company performance, and to validate practices like share ownership guidelines, clawbacks, capped payouts and double-trigger change-in-control protections. The Board recommends a FOR vote, citing strong shareholder support at the 2025 meeting (~94% in favor), the use of independent compensation consultants, and alignment of pay with performance metrics and shareholder value. The proposal is advisory and not binding; the Board and the Talent and Compensation Committee will consider the outcome in future compensation design.
- 3
Appointment of Auditor
ManagementBoard: FORAppoint PricewaterhouseCoopers LLP as the Company's auditor until the 2027 Annual Meeting and authorize the Board to fix the auditor’s remuneration.
Director elections
Nominees on the ballot10
Independent
Tenure on this board
2.2 yrs
Also a director at
Tetra Technologies Inc (TTI)Mueller Water Products Inc (MWA)
Independent
Tenure on this board
0.9 yrs
Independent
Tenure on this board
10.0 yrs
Also a director at
Bausch & Lomb Corp (BLCO)
Independent
Tenure on this board
2.2 yrs
Also a director at
Pacira Biosciences Inc (PCRX)
Independent
Tenure on this board
1.0 yrs
Independent
Tenure on this board
4.1 yrs
Also a director at
Acadian Asset Management Inc (AAMI)Bausch & Lomb Corp (BLCO)
Independent
Tenure on this board
18.0 yrs
Independent
Tenure on this board
0.2 yrs
Independent
Tenure on this board
10.1 yrs
Ownership
Latest 13F quarterTop institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | PAULSON CO. INC. | 19.6% | 73,255,869 | $396M |
| 2 | GOLDENTREE ASSET MANAGEMENT LP | 9.3% | 34,665,731 | $187M |
| 3 | NOMURA HOLDINGS INC | 2.4% | 8,986,372 | $49M |
| 4 | HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 2.1% | 8,000,000 | $43M |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 2.0% | 7,403,759 | $40M |
| 6 | MFN Partners Management, LP | 1.6% | 6,000,000 | $32M |
| 7 | Kohlberg Kravis Roberts Co. L.P. | 1.4% | 5,235,000 | $28M |
| 8 | ROYAL BANK OF CANADA | 1.4% | 5,200,000 | $28M |
| 9 | ING GROEP NV | 1.3% | 5,000,000 | $27M |
| 10 | Hudson Bay Capital Management LP | 1.3% | 5,000,000 | $27M |
Peers
Nearest market capOther Healthcare sector meetings6
Upcoming shareholder meetings at Bausch Health Companies Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Trulieve Cannabis CorpTRLV
Special meeting·Aug 5, 2026·$1.7B
Anaptysbio IncANAB
Annual meeting·Aug 11, 2026·$1.7B
Prestige Consumer Healthcare IncPBH
Annual meeting·Aug 4, 2026·$2.4B
Avanos Medical IncAVNS
Special meeting·Jul 22, 2026·$1.2B
Aura Biosciences IncAURA
Special meeting·Aug 5, 2026·$723M
Indaptus Therapeutics IncINDP
Annual meeting·Aug 10, 2026·$287M
Reference
Frequently asked questions
- When is the Bausch Health Companies Inc 2026 annual meeting?
- Bausch Health Companies Inc (BHC) holds its 2026 annual shareholder meeting on Tuesday, May 19, 2026.
- What is the record date for the Bausch Health Companies Inc 2026 meeting?
- The record date for the Bausch Health Companies Inc 2026 meeting is Friday, March 20, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Bausch Health Companies Inc's 2026 meeting?
- The board is presenting 10 director nominees at the Bausch Health Companies Inc 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Bausch Health Companies Inc 2026 meeting?
- Shareholders will vote on 3 proposals at the Bausch Health Companies Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.